Efficacy and safety of tocilizumab in refractory rheumatoid arthritis: a real life cohort from a single centre
Articolo
Data di Pubblicazione:
2014
Citazione:
Efficacy and safety of tocilizumab in refractory rheumatoid arthritis: a real life cohort from a single centre / Addimanda, Olga; Possemato, Niccolò; Macchioni, Pierluigi; Salvarani, Carlo. - In: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. - ISSN 0392-856X. - 32:4(2014), pp. 460-464.
Abstract:
Tocilizumab (TCZ) is an effective treatment in patients with rheumatoid arthritis (RA) refractory to anti-tumour necrosis factor-α. However, only few studies in real life have evaluated the efficacy of TCZ in long-standing rheumatoid arthritis (LSRA). Our aim was to evaluate the efficacy and safety of tocilizumab in refractory LSRA.
Tipologia CRIS:
Articolo su rivista
Keywords:
Adult; Aged; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Biological Markers; Biological Products; Drug Substitution; Drug Therapy, Combination; Female; Humans; Italy; Male; Middle Aged; Predictive Value of Tests; Severity of Illness Index; Steroids; Time Factors; Treatment Outcome
Elenco autori:
Addimanda, Olga; Possemato, Niccolò; Macchioni, Pierluigi; Salvarani, Carlo
Link alla scheda completa:
Pubblicato in: